午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

RD International Technology Co., Limited

RD International Technology Co., Limited

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 020-82000279
Mobile: 18024082417
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
CX-6258 hydrochloride hydrate C26H27Cl2N3O4 1353858-99-7 Details
CX-6258 hydrochloride C26H25Cl2N3O3 1353859-00-3 Details
Zorifertinib C22H23ClFN5O3 1626387-80-1 Details
Lifirafenib C25H17F3N4O3 1446090-79-4 Details
CHZ868 C22H19F2N5O2 1895895-38-1 Details
Lavendustin A C21H19NO6 125697-92-9 Details
PIM-447 dihydrochloride C24H23F3N4O 1820565-69-2 Details
JAK3-IN-1 C26H30ClN7O2 1805787-93-2 Details
Ilginatinib maleate C25H24FN7O4 1354799-87-3 Details
Ilginatinib C21H20FN7 1239358-86-1 Details
Ilginatinib hydrochloride C21H21ClFN7 1239358-85-0 Details
Naquotinib mesylate C31H46N8O6S 1448237-05-5 Details
EGFR-IN-3 C29H28F2N6O2 1660963-42-7 Details
Avitinib maleate C30H30FN7O6 1557268-88-8 Details
NRC-2694 C24H26N4O3 936446-61-6 Details
PF-06459988 C19H22ClN7O3 1428774-45-1 Details
Neratinib C30H29ClN6O3 698387-09-6 Details
Tarlox-TKI C19H18BrClN6O 2135696-72-7 Details
Ruxolitinib (S enantiomer) C17H18N6 941685-37-6 Details
Lestaurtinib C26H21N3O4 111358-88-4 Details
Alantolactone C15H20O2 546-43-0 Details
AZD1208 C21H21N3O2S 1204144-28-4 Details
Ochromycinone C19H14O4 111540-00-2 Details
GDC-0339 C20H22F3N7OS 1428569-85-0 Details
Osimertinib dimesylate C29H37N7O5S 2070014-82-1 Details
Lapatinib ditosylate C36H34ClFN4O7S2 388082-77-7 Details
Gefitinib hydrochloride C22H25Cl2FN4O3 184475-55-6 Details
CX-6258 C26H24ClN3O3 1202916-90-2 Details
AG-825 C19H15N3O3S2 149092-50-2 Details
NSC 74859 C16H15NO7S 501919-59-1 Details
Icotinib Hydrochloride C22H22ClN3O4 1204313-51-8 Details
Mutated EGFR-IN-1 C25H31N7O 1421372-66-8 Details
Homoharringtonine C29H39NO9 26833-87-4 Details
Tarloxotinib bromide C24H24Br2ClN9O3 1636180-98-7 Details
Tyrphostin 23 C10H6N2O2 118409-57-7 Details
Diosgenin C27H42O3 512-04-9 Details
Artesunate C19H28O8 88495-63-0 Details
Rociletinib hydrobromide C27H29BrF3N7O3 1446700-26-0 Details
GLPG0634 analog C23H18N6O2 1206101-20-3 Details
Niclosamide olamine C15H15Cl2N3O5 1420-04-8 Details
Cryptotanshinone C19H20O3 35825-57-1 Details
Gefitinib D8 C22H24ClFN4O3 857091-32-8 Details
Nitidine chloride C21H18NO4+ 13063-04-2 Details
Curculigoside C22H26O11 85643-19-2 Details
TCS PIM-1 1 C18H11BrN2O2 491871-58-0 Details
Napabucasin C14H8O4 83280-65-3 Details
Khellin C14H12O5 82-02-0 Details
Cerdulatinib hydrochloride C20H28ClN7O3S 1369761-01-2 Details
Itacitinib adipate C32H33F4N9O5 1334302-63-4 Details
RGB-286638 C29H37Cl2N7O4 784210-87-3 Details
Baricitinib phosphate C16H20N7O6PS 1187595-84-1 Details
Mutant EGFR inhibitor C27H30ClN7O2 1421373-62-7 Details
Tephrosin C23H22O7 76-80-2 Details
Osimertinib mesylate C29H37N7O5S 1421373-66-1 Details
Scutellarin C21H18O12 27740-01-8 Details
Cyasterone C29H44O8 17086-76-9 Details
CP-724714 C27H27N5O3 383432-38-0 Details
Corylifol A C25H26O4 775351-88-7 Details
SH-4-54 C29H27F5N2O5S 1456632-40-8 Details
NVP-BSK805 dihydrochloride C27H29ClF2N6O 1942919-79-0 Details
AD80 C22H19F4N7O 1384071-99-1 Details
TBHQ C10H14O2 1948-33-0 Details
(Rac)-JBJ-04-125-02 C29H26FN5O3S 2140807-05-0 Details
Reticuline C19H23NO4 485-19-8 Details
Mogrol C30H52O4 88930-15-8 Details
NCB-0846 C21H21N5O2 1792999-26-8 Details
AX-15836 C32H40N8O5S 2035509-96-5 Details
Sulforaphene C6H9NOS2 592-95-0 Details
Ginsenoside Rk1 C42H70O12 494753-69-4 Details
M2698 C21H19ClF3N5O 1379545-95-5 Details
APS-2-79 C23H21N3O3 2002381-25-9 Details
ZD-4190 C19H16BrFN6O2 413599-62-9 Details
CK2/ERK8-IN-1 C11H9Br4N3O2 1085822-09-8 Details
EGFR Protein Tyrosine Kinase Substrate C48H73N11O17 945830-38-6 Details
Pertuzumab C17H27NO2 380610-27-5 Details
Garcinone C C23H26O7 76996-27-5 Details
GS-444217 C23H21N7O 1262041-49-5 Details
Astragaloside VI C47H78O19 84687-45-6 Details
JAK2-IN-6 C14H10ClN3OS2 353512-04-6 Details
SB 203580 hydrochloride C21H17ClFN3OS 869185-85-3 Details
LY3214996 C22H27N7O2S 1951483-29-6 Details
Trastuzumab C10H14N6O5 180288-69-1 Details
(E)-Necrosulfonamide C18H15N5O6S2 1360614-48-7 Details
β-Hydroxyisovalerylshikonin C21H24O7 7415-78-3 Details
RAF709 C28H29F3N4O4 1628838-42-5 Details
Hispidulin C16H12O6 1447-88-7 Details
Coumermycin A1 C55H59N5O20 4434-05-3 Details
GNE-495 C22H20FN5O2 1449277-10-4 Details
TC13172 C17H16N4O5S 2093393-05-4 Details
Mobocertinib C32H39N7O4 1847461-43-1 Details
Mobocertinib succinate C36H45N7O8 2389149-74-8 Details
Cetuximab C107H179N35O36S7 205923-56-4 Details
BRAF inhibitor C22H18F2N4O3S 918505-61-0 Details
JCN037 C16H11BrFN3O2 2305154-31-6 Details
Sorafenib Tosylate C21H16ClF3N4O3.C7H8O3S 475207-59-1 Details
Arnicolide D C19H24O5 34532-68-8 Details
Triacetylresveratrol C20H18O6 42206-94-0 Details
Brevilin A C20H26O5 16503-32-5 Details
Sorafenib C21H16ClF3N4O3 284461-73-0 Details
Chrysophanol C15H10O4 481-74-3 Details
Product Total: Product Page:
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99